Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States
2021 · Crohn s & Colitis 360 · 38 citations
https://doi.org/10.1093/crocol/otab002
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
2.6K
Citations
23
h-index
29
i10-index
Simon Hong is an academic researcher from NYU Langone Health. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Neurotransmitter Receptor Influence on Behavior. The author has an h-index of 23, co-authored 82 publications.
ORCID: 0000-0003-3802-1053https://doi.org/10.1093/crocol/otab002
https://doi.org/10.1016/s0016-5085(24)02995-0
https://doi.org/10.1016/s0016-5085(24)01715-3
https://doi.org/10.1016/s0016-5085(24)01714-1
Click to start Chat